PriceTargets.com logo

AstraZeneca - AZN Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: £104.12
  • Forecasted Upside: -0.11%
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
£104.24 As of 12/23/2024 09:36 AM ET
▲ +202 (1.98%)

This chart shows the closing price for AZN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AstraZeneca Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AZN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AZN

Analyst Price Target is £104.12
▼ -0.11% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for AstraZeneca in the last 3 months. The average price target is £104.12, with a high forecast of £150 and a low forecast of GBX 74. The average price target represents a -0.11% upside from the last price of £104.24.

This chart shows the closing price for AZN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 9 contributing investment analysts is to moderate buy stock in AstraZeneca. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
3/28/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
6/26/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
9/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
11/23/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
12/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/22/2024JPMorgan Chase & Co.Reiterated RatingOverweight£140
11/7/2024JPMorgan Chase & Co.Reiterated RatingOverweight£140
11/7/2024Shore CapitalReiterated RatingBuy
9/16/2024JPMorgan Chase & Co.Reiterated RatingOverweight
9/3/2024Deutsche Bank AktiengesellschaftReiterated RatingHold£110
9/2/2024Berenberg BankReiterated RatingBuy£150
8/5/2024Berenberg BankReiterated RatingBuy£150
7/25/2024Shore CapitalReiterated RatingBuy
7/12/2024Shore CapitalReiterated RatingBuy
7/2/2024Jefferies Financial GroupBoost TargetHoldGBX 71 ➝ GBX 74
6/18/2024Deutsche Bank AktiengesellschaftReiterated RatingHold£110
6/7/2024Berenberg BankBoost TargetBuy£130 ➝ £150
6/4/2024JPMorgan Chase & Co.Reiterated RatingOverweight
5/28/2024CitigroupReiterated RatingBuy
5/21/2024JPMorgan Chase & Co.Reiterated RatingOverweight
5/21/2024Jefferies Financial GroupReiterated RatingHold£113
5/21/2024Shore CapitalReiterated RatingBuy
5/3/2024Berenberg BankBoost TargetBuy£120 ➝ £130
4/23/2024Deutsche Bank AktiengesellschaftReiterated RatingHold£105
4/15/2024Deutsche Bank AktiengesellschaftUpgradeHold
4/15/2024Shore CapitalReiterated RatingBuy
4/8/2024BarclaysReiterated RatingOverweight£125
4/5/2024Shore CapitalReiterated RatingBuy
4/4/2024JPMorgan Chase & Co.Reiterated RatingOverweight
3/13/2024Berenberg BankReiterated RatingBuy
3/12/2024Deutsche Bank AktiengesellschaftReiterated RatingSell
2/27/2024Deutsche Bank AktiengesellschaftReiterated RatingSellGBX 9,500
2/20/2024JPMorgan Chase & Co.Reiterated RatingOverweight£125
2/16/2024Jefferies Financial GroupReiterated RatingHold£110
2/12/2024BMO Capital MarketsReiterated RatingOutperform
2/12/2024UBS GroupLower TargetSell£107 ➝ GBX 9,900
2/8/2024Shore CapitalReiterated RatingBuy
11/28/2023CitigroupReiterated RatingBuy
11/27/2023Jefferies Financial GroupLower TargetBuy£130 ➝ £125
11/21/2023Berenberg BankReiterated RatingBuy£125
11/20/2023BarclaysReiterated RatingBuy£135
11/17/2023JPMorgan Chase & Co.Reiterated RatingOverweight
11/9/2023Shore CapitalReiterated RatingBuy
10/24/2023Shore CapitalReiterated RatingBuy
10/3/2023Deutsche Bank AktiengesellschaftReiterated RatingHold
10/2/2023CitigroupReiterated RatingBuy
9/29/2023Shore CapitalReiterated RatingBuy
9/25/2023Morgan StanleyBoost Target£127 ➝ £129
9/22/2023Berenberg BankReiterated RatingBuy
9/12/2023BarclaysReiterated RatingOverweight£135
9/5/2023Deutsche Bank AktiengesellschaftReiterated RatingHold£110
9/4/2023Berenberg BankReiterated RatingBuy£133
8/30/2023Shore CapitalReiterated RatingBuy
8/7/2023Morgan StanleyBoost Target£126 ➝ £127
7/28/2023Shore CapitalReiterated RatingBuy
7/18/2023CitigroupReiterated RatingBuy
7/13/2023Morgan StanleyLower Target£132 ➝ £126
7/12/2023UBS GroupUpgradeBuy
7/10/2023JPMorgan Chase & Co.Reiterated RatingOverweight
7/4/2023CitigroupReiterated RatingBuy
7/3/2023Shore CapitalReiterated RatingBuy
6/22/2023CitigroupReiterated RatingBuy
6/13/2023Deutsche Bank AktiengesellschaftReiterated RatingBuy£130
6/7/2023Shore CapitalReiterated RatingBuy
6/6/2023BarclaysReiterated RatingOverweight
6/5/2023JPMorgan Chase & Co.Reiterated RatingOverweight
5/26/2023Shore CapitalReiterated RatingBuy
5/16/2023Deutsche Bank AktiengesellschaftReiterated RatingBuy£130
5/15/2023Shore CapitalReiterated RatingBuy
5/3/2023Deutsche Bank AktiengesellschaftReiterated RatingBuy£130
4/28/2023JPMorgan Chase & Co.Boost Target£135 ➝ £140
4/27/2023Shore CapitalReiterated RatingBuy
4/12/2023BarclaysReiterated RatingOverweight
4/11/2023Morgan StanleyUpgradeOverweight
4/11/2023GuggenheimLower Target£127 ➝ £119
4/4/2023Deutsche Bank AktiengesellschaftReiterated RatingBuy£130
3/16/2023Berenberg BankSet Target£124
3/13/2023Deutsche Bank AktiengesellschaftSet Target£130
3/10/2023UBS GroupSet Target£119
3/9/2023JPMorgan Chase & Co.Set Target£135
3/9/2023Shore CapitalReiterated RatingBuy
3/7/2023Deutsche Bank AktiengesellschaftReiterated RatingBuy£130
3/2/2023JPMorgan Chase & Co.Set Target£135
2/21/2023UBS GroupSet Target£119
2/13/2023Deutsche Bank AktiengesellschaftSet Target£130
2/10/2023BarclaysReiterated RatingOverweight£135
2/10/2023Credit Suisse GroupSet Target£118
2/10/2023UBS GroupSet Target£101
2/9/2023JPMorgan Chase & Co.Set Target£135
2/9/2023Jefferies Financial GroupSet Target£108
2/9/2023The Goldman Sachs GroupSet TargetGBX 6,950
2/9/2023Shore CapitalReiterated RatingBuy
2/7/2023Deutsche Bank AktiengesellschaftSet Target£130
2/1/2023Berenberg BankReiterated RatingBuy
1/31/2023JPMorgan Chase & Co.Set Target£135
1/25/2023BarclaysBoost TargetOverweight£125 ➝ £135
1/20/2023JPMorgan Chase & Co.Reiterated RatingOverweight
1/18/2023Berenberg BankBoost TargetBuy£118 ➝ £126
1/12/2023Deutsche Bank AktiengesellschaftSet Target£130
1/10/2023BarclaysSet Target£125
1/9/2023UBS GroupSet Target£101
1/9/2023JPMorgan Chase & Co.Set Target£135
1/6/2023Credit Suisse GroupSet Target£118
1/5/2023Jefferies Financial GroupSet Target£108
1/4/2023BarclaysSet Target£125
1/3/2023JPMorgan Chase & Co.Set Target£135
12/29/2022BarclaysSet Target£125
12/23/2022BarclaysSet Target£125
12/15/2022JPMorgan Chase & Co.Set Target£125
12/15/2022Deutsche Bank AktiengesellschaftSet Target£130
12/14/2022Jefferies Financial GroupSet Target£105
12/12/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
12/9/2022Shore CapitalReiterated RatingBuy
12/5/2022Deutsche Bank AktiengesellschaftSet Target£120
11/29/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
11/22/2022Berenberg BankReiterated RatingBuy£118
11/18/2022Shore CapitalReiterated RatingBuy
11/16/2022CitigroupReiterated RatingBuy
11/11/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
11/11/2022BarclaysReiterated RatingOverweight£125
11/10/2022JPMorgan Chase & Co.Set Target£125
11/10/2022The Goldman Sachs GroupSet TargetGBX 6,950
11/10/2022UBS GroupSet Target£101
11/10/2022Jefferies Financial GroupSet TargetGBX 9,800
11/10/2022Shore CapitalReiterated RatingBuy
11/2/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
11/2/2022BarclaysSet Target£125
11/1/2022CitigroupReiterated RatingBuy£130
10/27/2022BarclaysReiterated RatingOverweight£125
10/26/2022Shore CapitalReiterated RatingBuy
10/25/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
10/21/2022Credit Suisse GroupReiterated RatingNeutral£110
10/19/2022Berenberg BankLower TargetBuy£120 ➝ £118
10/18/2022Deutsche Bank AktiengesellschaftSet Target£120
10/18/2022Shore CapitalReiterated RatingBuy
10/10/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
10/7/2022JPMorgan Chase & Co.Reiterated RatingOverweight£125
10/5/2022Credit Suisse GroupSet Target£110
10/4/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
10/3/2022CitigroupReiterated RatingBuy
9/21/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
9/19/2022JPMorgan Chase & Co.Set Target£125
9/15/2022Credit Suisse GroupDowngradeNeutral£110
9/15/2022BarclaysReiterated RatingOverweight£125
9/14/2022Jefferies Financial GroupSet TargetGBX 9,800
9/14/2022Berenberg BankReiterated RatingBuy£120
9/13/2022JPMorgan Chase & Co.Set Target£125
9/8/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
9/7/2022JPMorgan Chase & Co.Reiterated RatingOverweight£125
9/5/2022Shore CapitalReiterated RatingBuy
8/31/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
8/25/2022Shore CapitalReiterated RatingBuy
8/23/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
8/8/2022JPMorgan Chase & Co.Reiterated RatingOverweight£125
8/8/2022Shore CapitalReiterated RatingBuy
8/4/2022BarclaysBoost TargetOverweight£120 ➝ £125
8/1/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£120
8/1/2022Credit Suisse GroupSet Target£110
7/26/2022Berenberg BankReiterated RatingBuy£115
7/22/2022Shore CapitalReiterated RatingBuy
7/18/2022BarclaysReiterated RatingOverweight£120
7/14/2022Deutsche Bank AktiengesellschaftSet Target£115
7/13/2022JPMorgan Chase & Co.Set Target£120
7/12/2022CitigroupReiterated RatingBuy
7/12/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
7/11/2022Berenberg BankReiterated RatingBuy
7/7/2022Jefferies Financial GroupSet TargetGBX 9,800
7/7/2022JPMorgan Chase & Co.Reiterated RatingOverweight£120
7/5/2022Deutsche Bank AktiengesellschaftSet Target£115
6/29/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
6/28/2022Shore CapitalReiterated RatingBuy
6/22/2022CitigroupReiterated RatingBuy£105
6/21/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
6/14/2022UBS GroupSet Target£101
6/7/2022Credit Suisse GroupSet Target£110
6/7/2022Berenberg BankSet Target£120
6/6/2022Shore CapitalReiterated RatingNot Rated
6/6/2022JPMorgan Chase & Co.Set Target£120
6/1/2022Berenberg BankSet Target£120
5/31/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
5/30/2022BarclaysReiterated RatingOverweight£120
5/26/2022Berenberg BankReiterated RatingBuy£120
5/25/2022JPMorgan Chase & Co.Reiterated RatingOverweight£120
5/23/2022Deutsche Bank AktiengesellschaftSet Target£115
5/19/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
5/17/2022Deutsche Bank AktiengesellschaftSet Target£115
5/16/2022Berenberg BankReiterated RatingBuy£120
5/11/2022Morgan StanleyReiterated RatingOverweight
5/11/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
5/9/2022BarclaysReiterated RatingOverweight£120
5/6/2022Berenberg BankReiterated RatingBuy£120
5/3/2022Credit Suisse GroupSet Target£110
5/3/2022Deutsche Bank AktiengesellschaftSet Target£115
5/3/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
5/3/2022JPMorgan Chase & Co.Set Target£120
4/29/2022BarclaysReiterated RatingOverweight£120
4/29/2022The Goldman Sachs GroupSet TargetGBX 6,950
4/29/2022Jefferies Financial GroupSet TargetGBX 9,500
4/27/2022JPMorgan Chase & Co.Set Target£120
4/20/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£115
4/19/2022Jefferies Financial GroupSet TargetGBX 9,500
4/13/2022BarclaysReiterated RatingOverweight£115
4/13/2022JPMorgan Chase & Co.Set Target£120
4/11/2022Berenberg BankBoost TargetBuy£100 ➝ £120
4/8/2022Credit Suisse GroupSet Target£110
4/7/2022JPMorgan Chase & Co.Set Target£120
4/6/2022Deutsche Bank AktiengesellschaftSet Target£115
4/5/2022JPMorgan Chase & Co.Reiterated RatingOverweight£100
4/5/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
4/4/2022BarclaysReiterated RatingOverweight£115
3/30/2022Deutsche Bank AktiengesellschaftSet Target£105
3/29/2022Berenberg BankReiterated RatingBuy£100
3/21/2022Berenberg BankReiterated RatingBuy£100
3/21/2022BarclaysReiterated RatingOverweight£115
3/21/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
3/15/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
3/8/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
3/7/2022UBS GroupSet Target£105
3/7/2022BarclaysReiterated RatingOverweight£115
3/1/2022Berenberg BankReiterated RatingBuy£100
2/23/2022JPMorgan Chase & Co.Reiterated RatingOverweight£100
2/22/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
2/22/2022UBS GroupSet Target£100
2/17/2022BarclaysReiterated RatingOverweight£115
2/16/2022Berenberg BankReiterated RatingBuy£100
2/16/2022UBS GroupSet Target£100
2/16/2022Jefferies Financial GroupSet TargetGBX 8,800
2/15/2022JPMorgan Chase & Co.Set Target£100
2/14/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
2/11/2022BarclaysReiterated RatingOverweight£115
2/10/2022The Goldman Sachs GroupSet TargetGBX 6,950
2/10/2022UBS GroupSet Target£100
2/10/2022Jefferies Financial GroupSet TargetGBX 9,100
2/9/2022Morgan StanleyReiterated RatingOverweight
2/8/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
1/31/2022BarclaysReiterated RatingOverweight£115
1/24/2022BarclaysReiterated RatingOverweight£115
1/24/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
1/19/2022JPMorgan Chase & Co.Set Target£100
1/18/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
1/10/2022JPMorgan Chase & Co.Set Target£100
1/6/2022Berenberg BankReiterated RatingBuy£100
1/5/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
1/4/2022JPMorgan Chase & Co.Set Target£100
12/16/2021CitigroupReiterated RatingBuy£105
12/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
12/9/2021Berenberg BankLower TargetBuy£105 ➝ £100
12/7/2021Jefferies Financial GroupSet TargetGBX 9,100
12/6/2021Liberum CapitalReiterated RatingBuy
11/30/2021Berenberg BankReiterated RatingBuy£105
11/30/2021BarclaysReiterated RatingOverweight£110
11/30/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
11/22/2021Kepler Capital MarketsSet TargetGBX 9,500
11/18/2021UBS GroupSet Target£100
11/15/2021Credit Suisse GroupSet TargetGBX 9,000
11/15/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
11/12/2021The Goldman Sachs GroupSet TargetGBX 6,950
11/12/2021JPMorgan Chase & Co.Set Target£100
11/12/2021Jefferies Financial GroupSet TargetGBX 9,950
11/12/2021UBS GroupSet Target£100
11/10/2021BarclaysBoost TargetOverweight£100 ➝ £110
11/9/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
11/2/2021UBS GroupSet Target£100
10/26/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
10/21/2021JPMorgan Chase & Co.Reiterated RatingOverweight£100
10/20/2021Credit Suisse GroupSet TargetGBX 9,000
10/18/2021Kepler Capital MarketsSet TargetGBX 9,800
10/15/2021UBS GroupSet TargetGBX 9,200
10/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight£100
10/11/2021BarclaysReiterated RatingOverweight£100
10/11/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£105
10/8/2021Berenberg BankBoost TargetBuy£100 ➝ £105
9/30/2021Jefferies Financial GroupSet TargetGBX 9,950
9/29/2021Deutsche Bank AktiengesellschaftSet Target£102
9/27/2021Credit Suisse GroupSet TargetGBX 9,000
9/27/2021JPMorgan Chase & Co.Set Target£100
9/24/2021Jefferies Financial GroupSet TargetGBX 9,950
9/24/2021UBS GroupSet TargetGBX 9,200
9/21/2021JPMorgan Chase & Co.Set Target£100
9/20/2021CitigroupReiterated RatingBuy£105
9/20/2021Credit Suisse GroupSet TargetGBX 9,000
9/17/2021Morgan StanleySet Target£100
9/15/2021UBS GroupSet TargetGBX 9,200
9/15/2021JPMorgan Chase & Co.Set Target£100
9/10/2021Credit Suisse GroupSet TargetGBX 9,000
9/1/2021Berenberg BankLower TargetBuy£100 ➝ GBX 9,500
9/1/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£102
9/1/2021JPMorgan Chase & Co.Set Target£100
8/26/2021JPMorgan Chase & Co.Set Target£100
8/25/2021Shore CapitalReiterated RatingBuy
8/23/2021UBS GroupSet TargetGBX 9,200
8/12/2021JPMorgan Chase & Co.Set Target£100
8/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£102
8/9/2021Morgan StanleyReiterated RatingOverweightGBX 9,800
8/9/2021Shore CapitalReiterated RatingBuy
8/9/2021The Goldman Sachs GroupSet TargetGBX 6,950
8/9/2021UBS GroupSet TargetGBX 9,200
7/30/2021Credit Suisse GroupSet TargetGBX 9,000
7/29/2021Shore CapitalReiterated RatingBuy
7/29/2021UBS GroupSet TargetGBX 9,200
7/21/2021UBS GroupSet TargetGBX 9,200
7/19/2021BarclaysReiterated RatingOverweight£100
7/16/2021Shore CapitalReiterated RatingBuy
7/14/2021UBS GroupSet TargetGBX 9,200
7/12/2021Jefferies Financial GroupSet TargetGBX 9,950
7/7/2021The Goldman Sachs GroupSet TargetGBX 6,950
6/25/2021Berenberg BankReiterated RatingBuyGBX 9,500
6/17/2021UBS GroupBoost TargetBuyGBX 8,000 ➝ GBX 9,200
6/8/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£102
6/8/2021Credit Suisse GroupSet TargetBuyGBX 9,000
6/7/2021Liberum CapitalReiterated RatingBuyGBX 9,220
6/7/2021UBS GroupSet TargetBuyGBX 8,000
6/4/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
6/4/2021Jefferies Financial GroupSet TargetBuyGBX 8,850
6/3/2021Kepler Capital MarketsSet TargetBuyGBX 9,000
6/2/2021Credit Suisse GroupReiterated RatingOutperformGBX 9,000
5/28/2021Kepler Capital MarketsSet TargetBuyGBX 9,000
5/20/2021UBS GroupSet TargetBuyGBX 8,000
5/11/2021Berenberg BankReiterated RatingBuyGBX 9,500
5/11/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
5/11/2021Deutsche Bank AktiengesellschaftSet TargetBuy£102
5/7/2021Shore CapitalReiterated RatingBuy
5/7/2021UBS GroupSet TargetBuyGBX 8,000
5/4/2021BarclaysReiterated RatingOverweight
5/4/2021Deutsche Bank AktiengesellschaftSet TargetBuy£102
5/3/2021DZ BankReiterated RatingSell
5/3/2021Kepler Capital MarketsSet TargetBuyGBX 9,200
5/3/2021Credit Suisse GroupSet TargetBuyGBX 9,000
4/30/2021UBS GroupSet TargetBuyGBX 8,000
4/30/2021Jefferies Financial GroupSet TargetBuyGBX 8,850
4/30/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
4/26/2021Shore CapitalReiterated RatingBuy
4/20/2021UBS GroupSet TargetBuyGBX 8,000
4/16/2021Berenberg BankReiterated RatingBuy
4/14/2021UBS GroupSet TargetBuyGBX 8,000
4/12/2021Shore CapitalReiterated RatingBuy
4/8/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£102
4/7/2021Credit Suisse GroupSet TargetBuyGBX 9,000
4/7/2021UBS GroupSet TargetBuyGBX 8,000
3/29/2021UBS GroupSet TargetBuyGBX 8,000
3/23/2021UBS GroupSet TargetBuyGBX 8,000
3/23/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
3/22/2021Shore CapitalReiterated RatingBuy
3/22/2021BarclaysSet TargetBuy£100
3/18/2021Deutsche Bank AktiengesellschaftBoost TargetBuy£100 ➝ £102
3/17/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
3/16/2021Jefferies Financial GroupSet TargetHold ➝ BuyGBX 8,850
3/8/2021Berenberg BankSet TargetBuyGBX 9,500
3/8/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£100
3/8/2021BarclaysSet TargetBuy£100
3/3/2021UBS GroupSet TargetBuyGBX 8,000
3/1/2021The Goldman Sachs GroupSet TargetSellGBX 6,800
2/25/2021UBS GroupSet TargetBuyGBX 8,000
2/24/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£100
2/24/2021CitigroupReiterated RatingBuy
2/23/2021Shore CapitalReiterated RatingBuy
2/18/2021UBS GroupSet TargetNeutralGBX 7,500
2/17/2021The Goldman Sachs GroupSet TargetSellGBX 6,575
2/16/2021Deutsche Bank AktiengesellschaftSet TargetBuy£100
2/12/2021Credit Suisse GroupSet TargetBuyGBX 9,000
2/11/2021Shore CapitalReiterated RatingBuy
2/11/2021The Goldman Sachs GroupSet TargetSellGBX 6,575
2/11/2021BarclaysSet TargetBuyGBX 9,000
2/11/2021Jefferies Financial GroupSet TargetNeutralGBX 8,250
2/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
2/8/2021UBS GroupSet TargetNeutralGBX 7,500
2/3/2021Deutsche Bank AktiengesellschaftSet TargetBuy£100
1/26/2021CitigroupReiterated RatingBuy
1/26/2021UBS GroupSet TargetNeutralGBX 7,500
1/22/2021The Goldman Sachs GroupSet TargetSellGBX 6,575
1/22/2021BarclaysSet TargetBuyGBX 9,000
1/21/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy£100
1/20/2021Credit Suisse GroupSet TargetBuyGBX 9,000
1/20/2021Jefferies Financial GroupSet TargetNeutralGBX 8,250
1/15/2021Deutsche Bank AktiengesellschaftSet TargetBuy£100
1/14/2021BarclaysReiterated RatingOverweight
1/14/2021UBS GroupSet TargetNeutralGBX 7,500
1/6/2021Shore CapitalReiterated RatingHold
1/4/2021The Goldman Sachs GroupSet TargetSellGBX 6,400
12/28/2020The Goldman Sachs GroupSet TargetSellGBX 6,400
12/21/2020The Goldman Sachs GroupSet TargetSellGBX 6,400
12/17/2020Liberum CapitalLower TargetBuyGBX 9,770 ➝ GBX 9,430
12/16/2020DZ BankReiterated RatingSell
12/15/2020UBS GroupSet TargetNeutralGBX 7,500
12/14/2020CitigroupReiterated RatingBuy
12/14/2020Kepler Capital MarketsSet TargetBuyGBX 9,200
12/14/2020Jefferies Financial GroupSet TargetNeutralGBX 8,500
12/14/2020Credit Suisse GroupSet TargetBuyGBX 9,500
12/14/2020The Goldman Sachs GroupSet TargetSellGBX 6,400
12/9/2020UBS GroupSet TargetNeutralGBX 7,500
12/7/2020Morgan StanleySet TargetBuyGBX 9,900
12/4/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
11/30/2020UBS GroupSet TargetNeutralGBX 7,500
11/23/2020Morgan StanleyBoost TargetEqual WeightGBX 9,000 ➝ GBX 9,400
11/23/2020BarclaysSet TargetBuyGBX 9,300
11/23/2020The Goldman Sachs GroupSet TargetSellGBX 6,400
11/23/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
11/23/2020UBS GroupSet TargetSellGBX 7,300
11/23/2020Jefferies Financial GroupSet TargetNeutralGBX 8,100
11/19/2020Berenberg BankReiterated RatingBuy
11/17/2020Shore CapitalReiterated RatingHold
11/17/2020Jefferies Financial GroupReiterated RatingBuyGBX 8,100
11/11/2020Jefferies Financial GroupSet TargetNeutralGBX 8,100
11/11/2020The Goldman Sachs GroupSet TargetSellGBX 6,400
11/10/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
11/6/2020Credit Suisse GroupSet TargetBuyGBX 9,500
11/5/2020UBS GroupSet TargetSellGBX 7,300
11/5/2020The Goldman Sachs GroupSet TargetSellGBX 6,300
11/5/2020Jefferies Financial GroupSet TargetNeutralGBX 8,100
11/2/2020JPMorgan Chase & Co.Reiterated RatingOverweightGBX 9,500
10/26/2020UBS GroupSet TargetSellGBX 7,300
10/19/2020The Goldman Sachs GroupSet TargetSellGBX 6,300
10/13/2020Jefferies Financial GroupSet TargetNeutralGBX 8,100
10/8/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
9/29/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
9/29/2020Berenberg BankReiterated RatingBuy£105
9/28/2020CitigroupReiterated RatingBuy
9/21/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
9/14/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
9/9/2020UBS GroupSet TargetSellGBX 7,300
9/9/2020BarclaysSet TargetBuyGBX 9,300
9/9/2020The Goldman Sachs GroupSet TargetSellGBX 6,300
9/9/2020Jefferies Financial GroupSet TargetNeutralGBX 8,000
9/8/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
8/3/2020The Goldman Sachs GroupReiterated RatingSellGBX 6,300
8/3/2020Credit Suisse GroupSet TargetBuyGBX 9,500
7/31/2020DZ BankBoost TargetSellGBX 7,300 ➝ GBX 7,500
7/29/2020Credit Suisse GroupReiterated RatingOutperformGBX 9,000 ➝ GBX 9,500
7/29/2020BarclaysBoost TargetOverweightGBX 9,200 ➝ GBX 9,300
7/28/2020Credit Suisse GroupSet TargetBuyGBX 9,000
7/28/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
7/27/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
7/27/2020Shore CapitalReiterated RatingBuy
7/27/2020UBS GroupReiterated RatingSell
7/22/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
7/21/2020UBS GroupReiterated RatingSellGBX 7,300
7/21/2020Morgan StanleyReiterated RatingEqual weightGBX 9,000
7/21/2020JPMorgan Chase & Co.Reiterated RatingOverweight
7/20/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
7/16/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
7/16/2020CitigroupReiterated RatingBuy
7/15/2020BarclaysReiterated RatingOverweight
7/14/2020Shore CapitalReiterated RatingBuy
7/9/2020Jefferies Financial GroupReiterated RatingHold
7/8/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
6/29/2020Jefferies Financial GroupReiterated RatingHold
6/22/2020Oddo BhfSet TargetSellGBX 7,600
6/22/2020Oddo SecuritiesDowngradeReduceGBX 8,100 ➝ GBX 7,600
6/22/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
6/19/2020JPMorgan Chase & Co.Reiterated RatingOverweightGBX 9,500 ➝ GBX 9,550
6/18/2020CitigroupReiterated RatingBuy
6/10/2020UBS GroupSet TargetSellGBX 7,300
6/9/2020Credit Suisse GroupReiterated RatingOutperform
6/9/2020Kepler Capital MarketsReiterated RatingBuyGBX 9,200
6/8/2020Credit Suisse GroupReiterated RatingOutperformGBX 9,000
6/8/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
6/8/2020JPMorgan Chase & Co.Reiterated RatingOverweight
6/8/2020CitigroupReiterated RatingBuy
6/4/2020UBS GroupReiterated RatingSellGBX 6,000 ➝ GBX 7,300
6/4/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
6/2/2020Bryan, Garnier & CoBoost TargetBuyGBX 8,780 ➝ GBX 9,100
6/1/2020JPMorgan Chase & Co.Reiterated RatingOverweight
6/1/2020CitigroupReiterated RatingBuy
5/29/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
5/29/2020JPMorgan Chase & Co.Reiterated RatingOverweightGBX 9,500
5/29/2020Liberum CapitalReiterated RatingBuy
5/28/2020UBS GroupSet TargetSellGBX 6,000
5/22/2020UBS GroupReiterated RatingSellGBX 6,000
5/20/2020BarclaysSet TargetBuyGBX 9,200
5/15/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
5/15/2020BarclaysReiterated RatingOverweight
5/14/2020UBS GroupReiterated RatingSell
5/14/2020JPMorgan Chase & Co.Set TargetBuyGBX 9,500
5/11/2020Jefferies Financial GroupBoost TargetHoldGBX 7,575 ➝ GBX 8,000
5/11/2020Bryan, Garnier & CoBoost TargetBuyGBX 8,550 ➝ GBX 8,780
5/11/2020Liberum CapitalReiterated RatingBuy
5/4/2020CitigroupReiterated RatingBuy
5/4/2020BarclaysSet TargetBuyGBX 9,200
5/1/2020DZ BankBoost TargetSellGBX 6,500 ➝ GBX 7,300
5/1/2020JPMorgan Chase & Co.Boost TargetOverweightGBX 8,500 ➝ GBX 9,500
4/30/2020Credit Suisse GroupBoost TargetOutperformGBX 8,500 ➝ GBX 9,000
4/30/2020HSBCBoost TargetReduceGBX 6,450 ➝ GBX 6,690
4/29/2020UBS GroupReiterated RatingSellGBX 6,000
4/29/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
4/29/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
4/29/2020Shore CapitalReiterated RatingBuy
4/29/2020Liberum CapitalReiterated RatingBuy
4/27/2020BarclaysReiterated RatingOverweightGBX 9,000 ➝ GBX 9,200
4/23/2020JPMorgan Chase & Co.Reiterated RatingOverweightGBX 8,500
4/21/2020Kepler Capital MarketsBoost TargetBuyGBX 7,700 ➝ GBX 8,300
4/17/2020Credit Suisse GroupReiterated RatingOutperformGBX 8,500
4/15/2020Morgan StanleyBoost TargetEqual weightGBX 8,250 ➝ GBX 8,600
4/15/2020Main First BankBoost TargetBuyGBX 8,100 ➝ GBX 8,800
4/15/2020Jefferies Financial GroupBoost TargetHoldGBX 7,475 ➝ GBX 7,575
4/14/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
4/14/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
4/14/2020CitigroupReiterated RatingBuy
4/14/2020Liberum CapitalReiterated RatingBuy
4/14/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,300
4/9/2020BarclaysReiterated RatingOverweightGBX 8,000
4/7/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
4/6/2020Liberum CapitalBoost TargetBuyGBX 8,810 ➝ GBX 8,870
4/6/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,300
4/3/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
3/31/2020Oddo BhfSet TargetBuyGBX 7,600
3/31/2020Oddo SecuritiesLower TargetBuyGBX 8,000 ➝ GBX 7,600
3/31/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,300
3/30/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
3/30/2020Liberum CapitalReiterated RatingBuy
3/30/2020Shore CapitalReiterated RatingBuy
3/20/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,300
3/18/2020Liberum CapitalReiterated RatingBuy
3/17/2020BarclaysLower TargetOverweightGBX 8,500 ➝ GBX 8,000
3/12/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
3/12/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/10/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/9/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
3/9/2020UBS GroupSet TargetSellGBX 6,000
3/6/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
3/6/2020Shore CapitalReiterated RatingBuy
3/6/2020Liberum CapitalReiterated RatingBuyGBX 8,810
3/3/2020UBS GroupReiterated RatingSellGBX 5,800 ➝ GBX 6,000
2/25/2020Deutsche Bank AktiengesellschaftLower TargetBuyGBX 8,400 ➝ GBX 8,300
2/18/2020Kepler Capital MarketsLower TargetBuyGBX 8,000 ➝ GBX 7,700
2/17/2020Credit Suisse GroupSet TargetBuyGBX 8,500
2/17/2020CitigroupReiterated RatingBuy
2/17/2020UBS GroupReiterated RatingSellGBX 5,800
2/17/2020BarclaysReiterated RatingOverweight
2/17/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,400
2/14/2020BarclaysSet TargetBuyGBX 8,500
2/14/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
2/14/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
2/14/2020Shore CapitalReiterated RatingBuy
2/14/2020Liberum CapitalReiterated RatingBuy
2/14/2020Jefferies Financial GroupReiterated RatingHoldGBX 7,475
2/6/2020JPMorgan Chase & Co.Set TargetBuyGBX 8,500
2/3/2020UBS GroupReiterated RatingSellGBX 5,800
1/31/2020JPMorgan Chase & Co.Reiterated RatingOverweightGBX 8,500
1/28/2020CitigroupReiterated RatingBuy
1/28/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,400
1/27/2020Shore CapitalReiterated RatingBuy
1/23/2020The Goldman Sachs GroupSet TargetSellGBX 6,000
1/22/2020Jefferies Financial GroupSet TargetNeutralGBX 7,475
1/22/2020Liberum CapitalBoost TargetBuyGBX 8,300 ➝ GBX 8,810
1/16/2020BarclaysBoost TargetOverweightGBX 8,300 ➝ GBX 8,500
1/16/2020Credit Suisse GroupBoost TargetOutperformGBX 8,200 ➝ GBX 8,500
1/13/2020Shore CapitalReiterated RatingBuy
1/7/2020Shore CapitalReiterated RatingBuy
1/7/2020Liberum CapitalReiterated RatingBuy
1/6/2020Morgan StanleyBoost TargetEqual weightGBX 7,400 ➝ GBX 8,100
1/6/2020JPMorgan Chase & Co.Boost TargetOverweightGBX 7,900 ➝ GBX 8,500
(Data available from 12/23/2019 forward)

News Sentiment Rating

0.76 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
5/27/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/26/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
7/26/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/25/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/24/2024
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/24/2024
  • 3 very positive mentions
  • 18 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
11/23/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/23/2024

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

AstraZeneca logo
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More

Today's Range

Now: £104.24
Low: £103.04
High: £104.38

50 Day Range

MA: £108.32
Low: 9,725
High: £120.39

52 Week Range

Now: £104.24
Low: 9,461
High: £133.88

Volume

427,079,594 shs

Average Volume

5,515,215 shs

Market Capitalization

£161.57 billion

P/E Ratio

3,309.21

Dividend Yield

1.97%

Beta

0.17

Frequently Asked Questions

What sell-side analysts currently cover shares of AstraZeneca?

The following Wall Street research analysts have issued stock ratings on AstraZeneca in the last twelve months: Barclays PLC, Berenberg Bank, BMO Capital Markets, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Shore Capital, and UBS Group AG.
View the latest analyst ratings for AZN.

What is the current price target for AstraZeneca?

0 Wall Street analysts have set twelve-month price targets for AstraZeneca in the last year. Their average twelve-month price target is £104.12, suggesting a possible downside of 0.1%. Berenberg Bank has the highest price target set, predicting AZN will reach £150 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of GBX 74 for AstraZeneca in the next year.
View the latest price targets for AZN.

What is the current consensus analyst rating for AstraZeneca?

AstraZeneca currently has 1 sell rating, 2 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AZN.

What other companies compete with AstraZeneca?

Other companies that are similar to AstraZeneca include GSK, Sophos Group plc (SOPH.L), HUTCHMED, Ithaca Energy and Grainger. Learn More about companies similar to AstraZeneca.

How do I contact AstraZeneca's investor relations team?

AstraZeneca's physical mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company's listed phone number is +44-20-73045000. The official website for AstraZeneca is www.astrazeneca.com. Learn More about contacing AstraZeneca investor relations.